Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study

NCT00405171 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT00405171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00405171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study
Lead sponsor
University Hospital, Caen
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
February 28, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral therapy, hiv infections, hypercholesterolemia